Myota
Blue Bell, US · Delaware corporation · 2 known investors
Find your way into Myota
1,099 people in our graph share verified history with the Myota team — schools, employers, funds. One of them is your warm intro.
Hannah Sealunlockedknows Thomas Gurry · together at University of Cambridge (overlapped)
×2knows the team · via Imperial College London
×4knows the team · via University of Cambridge
knows the team · via University of Geneva
knows the team · via Massachusetts Institute of Technology
×2knows the team · via University of Leeds
Myota makes prebiotic fibre supplements that blend multiple clinically tested fibre sources into a daily scoop to support gut microbiome health, blood sugar control, cholesterol, digestion, and cognitive function. Sold direct to consumers, the products include a general blend and a "Sensitive" low-FODMAP formulation for people with digestive issues.
Founders & leadership
TG
Thomas GurryinCo-founder (microbiome scientist)Thomas Gurry is a computational and systems biologist who co-founded Myota, which develops prebiotic fibre supplements designed to support gut microbiome health and related outcomes including blood sugar control and digestion.
CH
Caitlin HallinCo-founder (microbiome scientist)Caitlin Hall holds a PhD in neuroscience and is a registered dietitian in the UK and Australia with expertise in the gut microbiome–brain axis. As R&D Director at Myota, she oversees the clinical research program for the company's prebiotic fiber supplement line.
GG
Gabriel GumbsinExecutiveGabriel Gumbs leads Myota, which produces prebiotic fibre supplements for gut health and microbiome support. He has over 20 years of experience in technology and is a public speaker and co-host of the Privacy Please Podcast.
SS
Sergey SlipenchukExecutive
JC
James C. WalkerExecutive
SK
Samuel KouryNamed on SEC filing
SA
Stephen A. TullmanNamed on SEC filing
NW
Neal WalkerNamed on SEC filing
Board
IM
Ira M. LubertBoard director
JW
Jo WebberBoard director
Investors · 2
Reported raises · per SEC filings
Form D private placements$15.7M disclosed across 6 rounds · 2018–2026
▶$3MraisedFeb 2026 · 8 investors · Other TechnologyRule 506(b)
▶$3MraisedFeb 2026 · 8 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Ira M. LubertDirector
- Jo WebberDirector
- Gabriel GumbsExecutive Officer
- Sergey SlipenchukExecutive Officer
- James C. WalkerExecutive Officer
- Offering amount
- $3M
- Amount sold
- $3M
- First sale
- Jan 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.6MraisedApr 2025 · 16 investors · Other TechnologyRule 506(b)
▶$1.6MraisedApr 2025 · 16 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Gabriel GumbsExecutive Officer
- Neal WebberDirector
- Jo WebberDirector
- Sergey SlipenchukExecutive Officer
- Ira M. LubertDirector
- James C. WalkerExecutive Officer
- Offering amount
- $1.6M
- Amount sold
- $1.6M
- First sale
- Apr 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.3MraisedMar 2024 · 2 investors · Other TechnologyRule 506(b)
▶$2.3MraisedMar 2024 · 2 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Neal WalkerDirector
- Gabriel GumbsExecutive Officer
- Ira M. LubertDirector
- Sergey SlipenchukExecutive Officer
- Jo WebberDirector
- James C WalkerExecutive Officer, Director
- Offering amount
- $2.5M
- Amount sold
- $2.3M
- Proceeds to insiders
- $668.5K
- First sale
- Mar 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$985KraisedMay 2023 · 14 investors · Other TechnologyRule 506(b)
▶$985KraisedMay 2023 · 14 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- James C WalkerExecutive Officer, Director
- Sergey SlipenchukExecutive Officer
- Ira M. LubertDirector
- Neal WalkerDirector
- Jo WebberDirector
- Offering amount
- $1M
- Amount sold
- $985K
- Proceeds to insiders
- $110K
- First sale
- May 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5.8MraisedJun 2021 · 33 investors · Other TechnologyRule 506(b)
▶$5.8MraisedJun 2021 · 33 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- JAMES WALKERExecutive Officer, Director
- SERGEY SLIPENCHUKExecutive Officer
- A. STEPHEN WRAYExecutive Officer, Director
- JO WEBBERDirector
- NEAL WALKERDirector
- IRA LUBERTDirector
- Offering amount
- $6M
- Amount sold
- $5.8M
- Proceeds to insiders
- $270K
- First sale
- May 2021
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$2.1MraisedMay 2018 · 46 investors · Other TechnologyRule 506(b)
▶$2.1MraisedMay 2018 · 46 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Samuel KouryExecutive Officer, Director
- Stephen A. TullmanDirector
- James WalkerExecutive Officer, Director
- Neal WalkerDirector
- Sergey SlipenchukExecutive Officer
- Offering amount
- $2.1M
- Amount sold
- $2.1M
- Proceeds to insiders
- $200K
- First sale
- May 2018
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlapUbie90 shared keywordsUbie provides a free AI-powered symptom checker that generates a personalized report on possible causes of a user's symptoms and guidance on when to see a doctor, based on a short questionnaire developed with doctors. The consumer-facing digital health service operates in Japan, the United States, and other countries.
Allure86 shared keywordsAllure is a beauty journalism publication that provides product reviews, trend reporting, and expert guidance on makeup, hair, skincare, and wellness. The publication serves beauty consumers and industry professionals through its website, social channels, and subscription service.
Typology50 shared keywordsTypology sells skincare products, including formulations designed for sensitive and reactive skin. The company operates in the direct-to-consumer beauty and personal care space.
Companies competing with Myota for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Myota do?
- Myota makes prebiotic fibre supplements that blend multiple clinically tested fibre sources into a daily scoop to support gut microbiome health, blood sugar control, cholesterol, digestion, and cognitive function. Sold direct to consumers, the products include a general blend and a "Sensitive" low-FODMAP formulation for people with digestive issues.
- Who founded Myota?
- Myota was founded by Thomas Gurry, Caitlin Hall.
- Who are Myota's investors?
- Myota's investors include FoodLabs, PeakBridge VC.
- How much funding has Myota raised?
- Myota has disclosed $15.7M raised across 6 rounds.
- Where is Myota headquartered?
- Myota is headquartered in Blue Bell, US.